Trinity Biotech plc (TRIB)
NASDAQ: TRIB · Real-Time Price · USD
1.540
+0.060 (4.05%)
At close: Aug 28, 2025, 4:00 PM
1.500
-0.040 (-2.59%)
After-hours: Aug 28, 2025, 7:56 PM EDT
Trinity Biotech Employees
Trinity Biotech had 401 employees as of December 31, 2024. The number of employees increased by 21 or 5.53% compared to the previous year.
Employees
401
Change (1Y)
21
Growth (1Y)
5.53%
Revenue / Employee
$153,504
Profits / Employee
-$79,274
Market Cap
5.72M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 401 | 21 | 5.53% |
| Dec 31, 2023 | 380 | -18 | -4.52% |
| Dec 31, 2022 | 398 | -79 | -16.56% |
| Dec 31, 2021 | 477 | -66 | -12.15% |
| Dec 31, 2020 | 543 | -36 | -6.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TRIB News
- 7 days ago - Trinity Biotech Appoints Paul Tivnan as Non-Executive Director - GlobeNewsWire
- 8 days ago - Regulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation - GlobeNewsWire
- 14 days ago - Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service - GlobeNewsWire
- 16 days ago - Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor - GlobeNewsWire
- 21 days ago - Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service - GlobeNewsWire
- 5 weeks ago - Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - GlobeNewsWire
- 2 months ago - Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround - GlobeNewsWire
- 2 months ago - Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation - GlobeNewsWire